Good evening :)
Switch to
Place Order

Astec Lifesciences Ltd

ASTEC
MaterialsFertilizers & Agro Chemicals
SmallcapWith a market cap of ₹4,208 cr, stock is ranked 568
Moderate RiskStock is 2.48x as volatile as Nifty
2,128.800.84% (-18.05)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsFertilizers & Agro Chemicals
SmallcapWith a market cap of ₹4,208 cr, stock is ranked 568
Moderate RiskStock is 2.48x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
46.8410.610.07%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
13.562.642.31%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Astec LifeSciences Limited is an India-based holding company. The Company is engaged in agro chemicals, including fungicides and herbicides business. It manufactures a range of agrochemical active ingredients and pharmaceutical intermediates. The Company's products include agrochemicals, such as tebuconazole, propiconazole, hexaconazole, difenoconazole, epoxiconazole, cyproconazole, flutriafol, tricyclazole, metalaxyl and lambda cyhalothrin, and intermediates, such as 2, 4-dichloroacetophenone, 2-chloro-4-fluoro acetophenone, 4-methyl phthalic anhydride and thio bis-4-chloro thymol. The Company's multi-purpose production facilities are located in Dombivli, which is over 50 kilometers from Mumbai, and Mahad, which is over 180 kilometers from Mumbai. Its multi-purpose plants are based on 3,000 liters to 20,000 liters glasslined and stainless steel reactors. In addition, the Company has undertaken a number of custom synthesis projects for customers in Europe, Japan and the United States.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+442.06+534.54+562.79+687.04+35.73+47.52+65.04+89.86
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.52%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 11, 2022

Astec LifeSciences Limited has informed the Exchange about related party transaction for the half year ended September 2022 | Download

Astec LifeSciences Limited has informed the Exchange about related party transaction for the half year ended September 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 7, 2022

Astec LifeSciences Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call held on Monday, October 31, 2022.This aforementioned information is also made available on the website of the Company i.e., www.astecls.com Kindly take note of the above. | Download

Astec LifeSciences Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call held on Monday, October 31, 2022.This aforementioned information is also made available on the website of the Company i.e., www.astecls.com Kindly take note of the above. | Download

Cash Dividend 
Ex. DateJul 19, 2022

Final • Div/Share: ₹ 1.5

See all events